Share Price and Basic Stock Data
Last Updated: December 13, 2025, 8:52 am
| PEG Ratio | 6.03 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Saregama India Ltd has carved out a unique niche in the entertainment and media industry, transitioning from a traditional music company to a multifaceted digital content powerhouse. For FY 2025, the company reported revenues of ₹1,171 Cr, reflecting a significant growth trajectory from ₹737 Cr in FY 2023. This upward trend underscores Saregama’s successful strategy in expanding its digital footprint and diversifying its offerings. Notably, the latest quarterly sales data shows a strong performance in the December 2024 quarter, where revenues surged to ₹483 Cr, setting the stage for further growth. Despite a dip to ₹205 Cr in June 2024, the overall trajectory remains positive, suggesting resilience in the face of market fluctuations. The company’s ability to generate consistent revenue growth, especially during peak seasons, is indicative of its robust business model and effective management of content production and distribution. This adaptability is crucial, especially in a rapidly evolving digital landscape where consumer preferences are ever-changing.
Profitability and Efficiency Metrics
Turning to profitability, Saregama reported a net profit of ₹204 Cr for FY 2025, up from ₹185 Cr in FY 2023, showcasing a commendable ability to enhance margins despite rising operational costs. The operating profit margin (OPM) for the same period stood at 24%, reflecting a slight decline from 30% in FY 2023, which may raise some eyebrows. However, this is still a respectable figure within the sector. The interest coverage ratio (ICR) of 58.36x indicates that the company is well-positioned to meet its interest obligations, a reassuring sign for potential investors. Moreover, the return on equity (ROE) of 13.87% is competitive, although it has slightly softened from previous years, suggesting a need for Saregama to optimize its capital structure further. The company’s consistent focus on controlling expenses is evident in its ability to maintain operating profits even during challenging quarters, which highlights effective cost management strategies that could buffer against future volatility.
Balance Sheet Strength and Financial Ratios
Analyzing Saregama’s balance sheet reveals a solid financial foundation with total assets amounting to ₹2,095 Cr as of FY 2025. The company’s reserves of ₹1,642 Cr and minimal borrowings of just ₹3 Cr reflect a conservative financial strategy that minimizes risk exposure. This low debt level enhances the company’s financial flexibility, allowing it to invest in growth opportunities without the burden of heavy interest payments. The price-to-book value (P/BV) ratio of 6.70x indicates that investors are willing to pay a premium for the company’s growth prospects, though it also suggests that the stock might be considered overvalued compared to historical norms. On the liquidity front, Saregama appears comfortable with a current ratio of 2.87, indicating that it can easily cover short-term liabilities. However, the slight decline in return on capital employed (ROCE) to 16.51% might signal a need for more efficient utilization of capital in future projects.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Saregama India Ltd reflects a healthy mix of investor confidence. Promoters hold 59.65% of the company, a stable figure that suggests a strong commitment to the company’s long-term vision. Meanwhile, foreign institutional investors (FIIs) hold 16.82%, and domestic institutional investors (DIIs) account for 5.16%, indicating a growing interest from institutional players. The public float is at 18.04%, which, while not overly large, suggests that retail interest is present but could be expanded. The number of shareholders has also risen to 71,427, indicating increasing public engagement with the stock. This growing interest from diverse investor groups could be a positive signal for future capital raising efforts or strategic partnerships. However, the declining public share percentage might raise questions about the accessibility of shares to retail investors, potentially impacting liquidity in the long term.
Outlook, Risks, and Final Insight
Looking ahead, Saregama India Ltd faces both opportunities and challenges. The company’s robust revenue growth and strong balance sheet position it well to capitalize on the expanding digital content market. However, risks remain, particularly in the form of competitive pressures from both established players and new entrants in the entertainment sector. Additionally, fluctuations in consumer demand for digital content can affect revenue predictability. Investors should also be cautious of potential margin pressures due to rising content production costs, which could impact profitability. The company’s ability to innovate and adapt to changing market trends will be critical for sustaining growth. In conclusion, while Saregama appears well-positioned to navigate these challenges, investors should monitor operational efficiency and market dynamics closely to gauge the stock’s performance in the coming quarters.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hathway Bhawani Cabletel & Datacom Ltd | 11.3 Cr. | 13.9 | 21.7/13.0 | 70.4 | 2.19 | 0.00 % | 3.38 % | 2.25 % | 10.0 |
| G V Films Ltd | 95.1 Cr. | 0.51 | 0.80/0.30 | 0.61 | 0.00 % | 2.36 % | 2.68 % | 1.00 | |
| Encash Entertainment Ltd | 11.3 Cr. | 29.0 | / | 20.3 | 0.00 % | 4.70 % | 4.70 % | 10.0 | |
| Diksat Transworld Ltd | 211 Cr. | 120 | 148/100 | 329 | 14.1 | 0.00 % | 2.82 % | 0.24 % | 10.0 |
| Cyber Media (India) Ltd | 25.8 Cr. | 16.4 | 27.2/11.0 | 26.8 | 5.43 | 0.00 % | 4.52 % | % | 10.0 |
| Industry Average | 2,355.69 Cr | 122.49 | 232.05 | 37.13 | 0.21% | 15.66% | 12.68% | 6.15 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 166 | 185 | 182 | 204 | 163 | 172 | 204 | 263 | 205 | 242 | 483 | 241 | 207 |
| Expenses | 114 | 128 | 119 | 154 | 113 | 111 | 139 | 193 | 154 | 181 | 399 | 160 | 151 |
| Operating Profit | 52 | 57 | 63 | 49 | 50 | 61 | 66 | 70 | 51 | 61 | 84 | 80 | 55 |
| OPM % | 31% | 31% | 35% | 24% | 31% | 35% | 32% | 27% | 25% | 25% | 17% | 33% | 27% |
| Other Income | 10 | 11 | 15 | 17 | 18 | 13 | 15 | 18 | 12 | 13 | 16 | 23 | 14 |
| Interest | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 5 | 1 |
| Depreciation | 4 | 4 | 6 | 6 | 7 | 8 | 9 | 12 | 13 | 14 | 15 | 17 | 17 |
| Profit before tax | 56 | 63 | 71 | 58 | 59 | 66 | 70 | 76 | 51 | 59 | 84 | 82 | 51 |
| Tax % | 26% | 25% | 26% | 25% | 27% | 27% | 25% | 29% | 27% | 24% | 26% | 27% | 28% |
| Net Profit | 42 | 47 | 53 | 44 | 43 | 48 | 52 | 54 | 37 | 45 | 62 | 60 | 37 |
| EPS in Rs | 2.17 | 2.41 | 2.76 | 2.27 | 2.25 | 2.49 | 2.71 | 2.79 | 1.91 | 2.33 | 3.23 | 3.12 | 1.90 |
Last Updated: August 1, 2025, 12:30 pm
Below is a detailed analysis of the quarterly data for Saregama India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 207.00 Cr.. The value appears to be declining and may need further review. It has decreased from 241.00 Cr. (Mar 2025) to 207.00 Cr., marking a decrease of 34.00 Cr..
- For Expenses, as of Jun 2025, the value is 151.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 160.00 Cr. (Mar 2025) to 151.00 Cr., marking a decrease of 9.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 55.00 Cr.. The value appears to be declining and may need further review. It has decreased from 80.00 Cr. (Mar 2025) to 55.00 Cr., marking a decrease of 25.00 Cr..
- For OPM %, as of Jun 2025, the value is 27.00%. The value appears to be declining and may need further review. It has decreased from 33.00% (Mar 2025) to 27.00%, marking a decrease of 6.00%.
- For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 9.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 4.00 Cr..
- For Depreciation, as of Jun 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 17.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 51.00 Cr.. The value appears to be declining and may need further review. It has decreased from 82.00 Cr. (Mar 2025) to 51.00 Cr., marking a decrease of 31.00 Cr..
- For Tax %, as of Jun 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 27.00% (Mar 2025) to 28.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 60.00 Cr. (Mar 2025) to 37.00 Cr., marking a decrease of 23.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.90. The value appears to be declining and may need further review. It has decreased from 3.12 (Mar 2025) to 1.90, marking a decrease of 1.22.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:41 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 177 | 187 | 222 | 218 | 357 | 545 | 521 | 442 | 576 | 737 | 803 | 1,171 | 1,161 |
| Expenses | 160 | 184 | 209 | 209 | 320 | 507 | 461 | 312 | 377 | 516 | 554 | 894 | 872 |
| Operating Profit | 17 | 2 | 13 | 9 | 36 | 38 | 60 | 130 | 199 | 221 | 249 | 277 | 289 |
| OPM % | 10% | 1% | 6% | 4% | 10% | 7% | 12% | 29% | 35% | 30% | 31% | 24% | 25% |
| Other Income | 11 | 11 | 2 | 13 | 10 | 56 | 11 | 31 | 23 | 54 | 61 | 63 | 64 |
| Interest | 3 | 1 | 0 | 2 | 3 | 7 | 7 | 3 | 5 | 6 | 3 | 6 | 7 |
| Depreciation | 3 | 6 | 5 | 4 | 4 | 3 | 5 | 6 | 13 | 21 | 36 | 58 | 68 |
| Profit before tax | 22 | 6 | 9 | 16 | 39 | 85 | 60 | 152 | 204 | 248 | 271 | 276 | 277 |
| Tax % | 23% | -5% | 25% | 46% | 27% | 36% | 28% | 25% | 25% | 25% | 27% | 26% | |
| Net Profit | 17 | 6 | 7 | 9 | 28 | 54 | 44 | 113 | 153 | 185 | 198 | 204 | 203 |
| EPS in Rs | 1.09 | 0.39 | 0.39 | 0.48 | 1.64 | 3.11 | 2.53 | 6.47 | 7.91 | 9.61 | 10.25 | 10.59 | 10.52 |
| Dividend Payout % | 14% | 39% | 38% | 31% | 18% | 10% | 6% | 31% | 38% | 31% | 39% | 42% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -64.71% | 16.67% | 28.57% | 211.11% | 92.86% | -18.52% | 156.82% | 35.40% | 20.92% | 7.03% | 3.03% |
| Change in YoY Net Profit Growth (%) | 0.00% | 81.37% | 11.90% | 182.54% | -118.25% | -111.38% | 175.34% | -121.42% | -14.48% | -13.89% | -4.00% |
Saregama India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 18% |
| 3 Years: | 27% |
| TTM: | 39% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 38% |
| 5 Years: | 34% |
| 3 Years: | 8% |
| TTM: | 5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 59% |
| 3 Years: | 8% |
| 1 Year: | -2% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 15% |
| 3 Years: | 13% |
| Last Year: | 13% |
Last Updated: September 5, 2025, 1:26 pm
Balance Sheet
Last Updated: December 4, 2025, 1:55 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 19 | 19 | 19 | 19 | 19 |
| Reserves | 148 | 150 | 157 | 322 | 364 | 411 | 381 | 488 | 1,358 | 1,323 | 1,450 | 1,564 | 1,642 |
| Borrowings | 13 | 8 | 4 | 3 | 16 | 64 | 10 | 1 | 1 | 1 | 5 | 3 | 3 |
| Other Liabilities | 65 | 72 | 89 | 137 | 181 | 217 | 211 | 277 | 309 | 361 | 559 | 509 | 596 |
| Total Liabilities | 244 | 247 | 267 | 480 | 578 | 709 | 620 | 784 | 1,688 | 1,704 | 2,034 | 2,095 | 2,260 |
| Fixed Assets | 102 | 84 | 85 | 199 | 197 | 215 | 219 | 226 | 278 | 338 | 742 | 835 | 964 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 4 | 6 | 0 | 0 |
| Investments | 40 | 40 | 40 | 132 | 151 | 148 | 75 | 137 | 676 | 239 | 118 | 111 | 176 |
| Other Assets | 101 | 124 | 143 | 149 | 230 | 345 | 325 | 420 | 732 | 1,124 | 1,168 | 1,149 | 1,120 |
| Total Assets | 244 | 247 | 267 | 480 | 578 | 709 | 620 | 784 | 1,688 | 1,704 | 2,034 | 2,095 | 2,260 |
Below is a detailed analysis of the balance sheet data for Saregama India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,642.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,564.00 Cr. (Mar 2025) to 1,642.00 Cr., marking an increase of 78.00 Cr..
- For Borrowings, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 596.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 509.00 Cr. (Mar 2025) to 596.00 Cr., marking an increase of 87.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,260.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,095.00 Cr. (Mar 2025) to 2,260.00 Cr., marking an increase of 165.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 964.00 Cr.. The value appears strong and on an upward trend. It has increased from 835.00 Cr. (Mar 2025) to 964.00 Cr., marking an increase of 129.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 176.00 Cr.. The value appears strong and on an upward trend. It has increased from 111.00 Cr. (Mar 2025) to 176.00 Cr., marking an increase of 65.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,120.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,149.00 Cr. (Mar 2025) to 1,120.00 Cr., marking a decrease of 29.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,260.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,095.00 Cr. (Mar 2025) to 2,260.00 Cr., marking an increase of 165.00 Cr..
Notably, the Reserves (1,642.00 Cr.) exceed the Borrowings (3.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 4.00 | -6.00 | 9.00 | 6.00 | 20.00 | -26.00 | 50.00 | 129.00 | 198.00 | 220.00 | 244.00 | 274.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 77 | 106 | 76 | 87 | 75 | 74 | 76 | 72 | 68 | 73 | 72 | 45 |
| Inventory Days | 1,030 | 270 | 266 | 376 | 161 | |||||||
| Days Payable | 838 | 165 | 114 | 147 | 86 | |||||||
| Cash Conversion Cycle | 77 | 106 | 76 | 87 | 75 | 74 | 76 | 264 | 173 | 226 | 302 | 120 |
| Working Capital Days | 23 | 62 | 17 | 55 | 61 | 77 | 98 | 35 | 83 | 98 | 121 | 40 |
| ROCE % | 14% | 4% | 11% | 7% | 11% | 20% | 15% | 34% | 23% | 19% | 18% | 17% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ITI Small Cap Fund | 739,502 | 1.04 | 29.4 | 712,734 | 2025-12-15 08:26:51 | 3.76% |
| LIC MF Multi Cap Fund | 412,603 | 0.9 | 16.4 | 216,463 | 2025-12-08 03:11:19 | 90.61% |
| LIC MF Dividend Yield Fund | 185,810 | 1.06 | 7.39 | N/A | N/A | N/A |
| Bandhan Aggressive Hybrid Fund | 114,650 | 0.31 | 4.56 | N/A | N/A | N/A |
| LIC MF Midcap Fund | 61,238 | 0.7 | 2.43 | N/A | N/A | N/A |
| Navi ELSS Tax Saver Fund | 20,000 | 1.46 | 0.8 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 10.00 |
| Basic EPS (Rs.) | 10.62 | 10.27 | 9.63 | 8.43 | 65.61 |
| Diluted EPS (Rs.) | 10.61 | 10.27 | 9.63 | 8.42 | 64.97 |
| Cash EPS (Rs.) | 13.61 | 12.12 | 10.68 | 8.60 | 68.32 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 76.37 | 70.62 | 64.03 | 71.62 | 292.01 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 82.12 | 76.37 | 69.78 | 71.62 | 292.01 |
| Revenue From Operations / Share (Rs.) | 60.75 | 41.65 | 38.20 | 30.11 | 253.59 |
| PBDIT / Share (Rs.) | 17.38 | 16.09 | 14.24 | 11.52 | 92.36 |
| PBIT / Share (Rs.) | 14.36 | 14.21 | 13.16 | 10.84 | 89.14 |
| PBT / Share (Rs.) | 14.32 | 14.04 | 12.87 | 10.60 | 87.16 |
| Net Profit / Share (Rs.) | 10.59 | 10.25 | 9.60 | 7.92 | 65.10 |
| NP After MI And SOA / Share (Rs.) | 10.59 | 10.25 | 9.61 | 7.91 | 64.58 |
| PBDIT Margin (%) | 28.60 | 38.63 | 37.27 | 38.24 | 36.42 |
| PBIT Margin (%) | 23.63 | 34.12 | 34.45 | 35.98 | 35.15 |
| PBT Margin (%) | 23.56 | 33.72 | 33.67 | 35.20 | 34.37 |
| Net Profit Margin (%) | 17.43 | 24.60 | 25.12 | 26.28 | 25.67 |
| NP After MI And SOA Margin (%) | 17.43 | 24.60 | 25.16 | 26.28 | 25.46 |
| Return on Networth / Equity (%) | 13.87 | 14.54 | 15.05 | 11.07 | 22.25 |
| Return on Capital Employeed (%) | 16.51 | 15.77 | 18.17 | 14.48 | 27.52 |
| Return On Assets (%) | 9.74 | 9.71 | 10.87 | 9.04 | 14.35 |
| Asset Turnover Ratio (%) | 0.56 | 0.42 | 0.43 | 0.46 | 0.62 |
| Current Ratio (X) | 2.87 | 4.12 | 4.07 | 5.01 | 1.97 |
| Quick Ratio (X) | 2.30 | 3.31 | 3.53 | 4.58 | 1.65 |
| Inventory Turnover Ratio (X) | 4.89 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 42.47 | 39.03 | 31.20 | 37.90 | 33.29 |
| Dividend Payout Ratio (CP) (%) | 33.05 | 32.99 | 28.05 | 34.90 | 31.71 |
| Earning Retention Ratio (%) | 57.53 | 60.97 | 68.80 | 62.10 | 66.71 |
| Cash Earning Retention Ratio (%) | 66.95 | 67.01 | 71.95 | 65.10 | 68.29 |
| Interest Coverage Ratio (X) | 58.36 | 95.68 | 48.05 | 49.13 | 46.65 |
| Interest Coverage Ratio (Post Tax) (X) | 35.71 | 61.94 | 33.38 | 34.78 | 33.88 |
| Enterprise Value (Cr.) | 9323.79 | 6139.98 | 5870.35 | 92776.36 | 2636.35 |
| EV / Net Operating Revenue (X) | 7.96 | 7.65 | 7.97 | 159.79 | 5.97 |
| EV / EBITDA (X) | 27.83 | 19.79 | 21.38 | 417.85 | 16.38 |
| MarketCap / Net Operating Revenue (X) | 8.42 | 8.31 | 8.65 | 160.34 | 6.29 |
| Retention Ratios (%) | 57.52 | 60.96 | 68.79 | 62.09 | 66.70 |
| Price / BV (X) | 6.70 | 4.92 | 5.18 | 67.57 | 5.49 |
| Price / Net Operating Revenue (X) | 8.42 | 8.31 | 8.65 | 160.34 | 6.29 |
| EarningsYield | 0.02 | 0.02 | 0.02 | 0.00 | 0.04 |
After reviewing the key financial ratios for Saregama India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 10.62. This value is within the healthy range. It has increased from 10.27 (Mar 24) to 10.62, marking an increase of 0.35.
- For Diluted EPS (Rs.), as of Mar 25, the value is 10.61. This value is within the healthy range. It has increased from 10.27 (Mar 24) to 10.61, marking an increase of 0.34.
- For Cash EPS (Rs.), as of Mar 25, the value is 13.61. This value is within the healthy range. It has increased from 12.12 (Mar 24) to 13.61, marking an increase of 1.49.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 76.37. It has increased from 70.62 (Mar 24) to 76.37, marking an increase of 5.75.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 82.12. It has increased from 76.37 (Mar 24) to 82.12, marking an increase of 5.75.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 60.75. It has increased from 41.65 (Mar 24) to 60.75, marking an increase of 19.10.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 17.38. This value is within the healthy range. It has increased from 16.09 (Mar 24) to 17.38, marking an increase of 1.29.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.36. This value is within the healthy range. It has increased from 14.21 (Mar 24) to 14.36, marking an increase of 0.15.
- For PBT / Share (Rs.), as of Mar 25, the value is 14.32. This value is within the healthy range. It has increased from 14.04 (Mar 24) to 14.32, marking an increase of 0.28.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 10.59. This value is within the healthy range. It has increased from 10.25 (Mar 24) to 10.59, marking an increase of 0.34.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 10.59. This value is within the healthy range. It has increased from 10.25 (Mar 24) to 10.59, marking an increase of 0.34.
- For PBDIT Margin (%), as of Mar 25, the value is 28.60. This value is within the healthy range. It has decreased from 38.63 (Mar 24) to 28.60, marking a decrease of 10.03.
- For PBIT Margin (%), as of Mar 25, the value is 23.63. This value exceeds the healthy maximum of 20. It has decreased from 34.12 (Mar 24) to 23.63, marking a decrease of 10.49.
- For PBT Margin (%), as of Mar 25, the value is 23.56. This value is within the healthy range. It has decreased from 33.72 (Mar 24) to 23.56, marking a decrease of 10.16.
- For Net Profit Margin (%), as of Mar 25, the value is 17.43. This value exceeds the healthy maximum of 10. It has decreased from 24.60 (Mar 24) to 17.43, marking a decrease of 7.17.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 17.43. This value is within the healthy range. It has decreased from 24.60 (Mar 24) to 17.43, marking a decrease of 7.17.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.87. This value is below the healthy minimum of 15. It has decreased from 14.54 (Mar 24) to 13.87, marking a decrease of 0.67.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.51. This value is within the healthy range. It has increased from 15.77 (Mar 24) to 16.51, marking an increase of 0.74.
- For Return On Assets (%), as of Mar 25, the value is 9.74. This value is within the healthy range. It has increased from 9.71 (Mar 24) to 9.74, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.56. It has increased from 0.42 (Mar 24) to 0.56, marking an increase of 0.14.
- For Current Ratio (X), as of Mar 25, the value is 2.87. This value is within the healthy range. It has decreased from 4.12 (Mar 24) to 2.87, marking a decrease of 1.25.
- For Quick Ratio (X), as of Mar 25, the value is 2.30. This value exceeds the healthy maximum of 2. It has decreased from 3.31 (Mar 24) to 2.30, marking a decrease of 1.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.89. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 4.89, marking an increase of 4.89.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 42.47. This value is within the healthy range. It has increased from 39.03 (Mar 24) to 42.47, marking an increase of 3.44.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 33.05. This value is within the healthy range. It has increased from 32.99 (Mar 24) to 33.05, marking an increase of 0.06.
- For Earning Retention Ratio (%), as of Mar 25, the value is 57.53. This value is within the healthy range. It has decreased from 60.97 (Mar 24) to 57.53, marking a decrease of 3.44.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 66.95. This value is within the healthy range. It has decreased from 67.01 (Mar 24) to 66.95, marking a decrease of 0.06.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 58.36. This value is within the healthy range. It has decreased from 95.68 (Mar 24) to 58.36, marking a decrease of 37.32.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 35.71. This value is within the healthy range. It has decreased from 61.94 (Mar 24) to 35.71, marking a decrease of 26.23.
- For Enterprise Value (Cr.), as of Mar 25, the value is 9,323.79. It has increased from 6,139.98 (Mar 24) to 9,323.79, marking an increase of 3,183.81.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.96. This value exceeds the healthy maximum of 3. It has increased from 7.65 (Mar 24) to 7.96, marking an increase of 0.31.
- For EV / EBITDA (X), as of Mar 25, the value is 27.83. This value exceeds the healthy maximum of 15. It has increased from 19.79 (Mar 24) to 27.83, marking an increase of 8.04.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.42. This value exceeds the healthy maximum of 3. It has increased from 8.31 (Mar 24) to 8.42, marking an increase of 0.11.
- For Retention Ratios (%), as of Mar 25, the value is 57.52. This value is within the healthy range. It has decreased from 60.96 (Mar 24) to 57.52, marking a decrease of 3.44.
- For Price / BV (X), as of Mar 25, the value is 6.70. This value exceeds the healthy maximum of 3. It has increased from 4.92 (Mar 24) to 6.70, marking an increase of 1.78.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.42. This value exceeds the healthy maximum of 3. It has increased from 8.31 (Mar 24) to 8.42, marking an increase of 0.11.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Saregama India Ltd:
- Net Profit Margin: 17.43%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.51% (Industry Average ROCE: 15.66%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.87% (Industry Average ROE: 12.68%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 35.71
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.3
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 35.4 (Industry average Stock P/E: 232.05)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 17.43%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Entertainment & Media | 33, Jessore Road, Dum Dum, Kolkata West Bengal 700028 | co.sec@saregama.com http://www.saregama.com |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Sanjiv Goenka | Chairman & Non-Exe.Director |
| Mrs. Avarna Jain | Vice Chairperson (Non-Executive) |
| Mr. Vikram Mehra | Managing Director |
| Mrs. Preeti Goenka | Non Executive Director |
| Mr. Umang Kanoria | Ind. Non-Executive Director |
| Mr. Santanu Bhattacharya | Ind. Non-Executive Director |
| Ms. Kusum Dadoo | Ind. Non-Executive Director |
| Mr. Noshir Naval Framjee | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Saregama India Ltd?
Saregama India Ltd's intrinsic value (as of 15 December 2025) is 308.90 which is 15.37% lower the current market price of 365.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 7,046 Cr. market cap, FY2025-2026 high/low of 604/340, reserves of ₹1,642 Cr, and liabilities of 2,260 Cr.
What is the Market Cap of Saregama India Ltd?
The Market Cap of Saregama India Ltd is 7,046 Cr..
What is the current Stock Price of Saregama India Ltd as on 15 December 2025?
The current stock price of Saregama India Ltd as on 15 December 2025 is 365.
What is the High / Low of Saregama India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Saregama India Ltd stocks is 604/340.
What is the Stock P/E of Saregama India Ltd?
The Stock P/E of Saregama India Ltd is 35.4.
What is the Book Value of Saregama India Ltd?
The Book Value of Saregama India Ltd is 86.2.
What is the Dividend Yield of Saregama India Ltd?
The Dividend Yield of Saregama India Ltd is 1.23 %.
What is the ROCE of Saregama India Ltd?
The ROCE of Saregama India Ltd is 17.2 %.
What is the ROE of Saregama India Ltd?
The ROE of Saregama India Ltd is 12.5 %.
What is the Face Value of Saregama India Ltd?
The Face Value of Saregama India Ltd is 1.00.